Medipress Health Limited Partnership Stock EBITDA
| MPRS Stock | 93.10 0.00 0.00% |
MediPress Health Limited Partnership fundamentals help investors to digest information that contributes to MediPress Health's financial success or failures. It also enables traders to predict the movement of MediPress Stock. The fundamental analysis module provides a way to measure MediPress Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to MediPress Health stock.
MediPress |
MediPress Health Limited Partnership Company EBITDA Analysis
MediPress Health's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
According to the company disclosure, MediPress Health Limited Partnership reported earnings before interest,tax, depreciation and amortization of 0.0. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as EBITDA (which currently averages 0.0) industry. This indicator is about the same for all Israel stocks average (which is currently at 0.0).
MediPress EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MediPress Health's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of MediPress Health could also be used in its relative valuation, which is a method of valuing MediPress Health by comparing valuation metrics of similar companies.MediPress Health is currently under evaluation in ebitda category among related companies.
MediPress Fundamentals
| Shares Owned By Insiders | 28.12 % |
About MediPress Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MediPress Health Limited Partnership's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MediPress Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MediPress Health Limited Partnership based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MediPress Health Limited Partnership. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Complementary Tools for MediPress Stock analysis
When running MediPress Health's price analysis, check to measure MediPress Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MediPress Health is operating at the current time. Most of MediPress Health's value examination focuses on studying past and present price action to predict the probability of MediPress Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MediPress Health's price. Additionally, you may evaluate how the addition of MediPress Health to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |